Home › NDC Lookup › RxCUI directory › RxCUI 835960

Amiodarone hydrochloride 300 MG Oral Tablet — RxCUI 835960

RxNorm drug concept · Semantic clinical drug
RxCUI 835960 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI835960
Official nameAmiodarone hydrochloride 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asamiodarone HCl 300 MG Oral Tablet
FDA products mapped4
Package NDCs mapped9
Reported Medicaid activity (SDUD)4,993 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amiodarone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Amiodarone is reserved for serious, life-threatening heart rhythms — specifically the kind that can cause sudden cardiac arrest. Doctors only reach for it when other medications ha...
  • Why is my doctor putting me on amiodarone instead of something simpler?
  • The most important thing is to be consistent. Food significantly increases how much amiodarone your body absorbs, so your doctor will tell you to always take it with food or always...
  • Should I take amiodarone with food or on an empty stomach?
📖 Read our full Amiodarone guide →

🕸️ Concept Web — How Amiodarone hydrochloride 300 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amiodarone hydrochloride 300 MG Oral Tablet RxCUI 835960

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Amiodarone 703
    • Amiodarone hydrochloride 203114
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amiodarone Oral Tablet 370568
    • Amiodarone hydrochloride Oral Tablet 2646262
    • Amiodarone Oral Product 1151982
    • Amiodarone Pill 1151983
    • Amiodarone hydrochloride Oral Product 2663592
    • Amiodarone hydrochloride Pill 2660021
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Amiodarone hydrochloride 300 MG 835959

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amiodarone hydrochloride 300 MG SCDC · 835959
  • Amiodarone Oral Tablet SCDF · 370568
  • Amiodarone hydrochloride Oral Tablet SCDFP · 2646262
  • Amiodarone Oral Product SCDG · 1151982
  • Amiodarone Pill SCDG · 1151983
  • Amiodarone hydrochloride Oral Product SCDGP · 2663592
  • Amiodarone hydrochloride Pill SCDGP · 2660021

📦 FDA Products & Package NDCs

4 products · 9 package NDCs
9 package NDCs map to RxCUI 835960 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51672-4025-02 500 TABLET in 1 BOTTLE (51672-4025-2) Amiodarone Hydrochloride Sun Pharmaceutical Industries, Inc. 2001-03-30
51672-4025-03 1000 TABLET in 1 BOTTLE (51672-4025-3) Amiodarone Hydrochloride Sun Pharmaceutical Industries, Inc. 2001-03-30
51672-4025-04 60 TABLET in 1 BOTTLE (51672-4025-4) Amiodarone Hydrochloride Sun Pharmaceutical Industries, Inc. 2001-03-30
51672-4055-06 30 TABLET in 1 BOTTLE (51672-4055-6) Amiodarone Hydrochloride Sun Pharmaceutical Industries, Inc. 2001-03-30
51672-4056-01 100 TABLET in 1 BOTTLE (51672-4056-1) Amiodarone Hydrochloride Sun Pharmaceutical Industries, Inc. 2003-12-02
51672-4056-03 1000 TABLET in 1 BOTTLE (51672-4056-3) Amiodarone Hydrochloride Sun Pharmaceutical Industries, Inc. 2003-12-02
51672-4056-06 30 TABLET in 1 BOTTLE (51672-4056-6) Amiodarone Hydrochloride Sun Pharmaceutical Industries, Inc. 2003-12-02
51672-4057-00 10 BLISTER PACK in 1 CARTON (51672-4057-0) / 10 TABLET in 1... Amiodarone Hydrochloride Sun Pharmaceutical Industries, Inc. 2002-11-29
51672-4057-06 30 TABLET in 1 BOTTLE (51672-4057-6) Amiodarone Hydrochloride Sun Pharmaceutical Industries, Inc. 2002-11-29
Observed labelers: Sun Pharmaceutical Industries, Inc. (9) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.